Hans H. Lindén

661 citations
9 papers · 502 indexed · h-index 6
Topics
Pharmaceutical Economics and Policy (5 papers)Biosimilars and Bioanalytical Methods (3 papers)Biomedical and Engineering Education (2 papers)

In The Last Decade

Hans H. Lindén

8 papers receiving 468 citations

Peers

Hans H. Lindén
Comparison fields: 5 of 101
  • Pharmaceutical Science 266
  • Materials Chemistry 155
  • Molecular Biology 101
  • Spectroscopy 70
  • Biomedical Engineering 53
Replace Qiufang Jing with:
Qiufang Jing China
Qianqian Zhao China
Jonas H. Fagerberg Sweden
Doo‐Man Oh United States
Kevin C. Johnson United States
Niklas J. Koehl Ireland
Rahul Dixit India
Ganesh Shete India
Kwame Nti-Addae United States
Yasushi Shono Japan
Hans H. Lindén relative to Qiufang Jing China Qiufang Jing's profile →
Citations per field
00.5×7.5×
Qiufang Jing · 1×
Citations per year

Countries citing papers authored by Hans H. Lindén

Since Specialization
Citations

This map shows the geographic impact of Hans H. Lindén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans H. Lindén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans H. Lindén more than expected).

Fields of papers citing papers by Hans H. Lindén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans H. Lindén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans H. Lindén. The network helps show where Hans H. Lindén may publish in the future.

Co-authorship network of co-authors of Hans H. Lindén

This figure shows the co-authorship network connecting the top 25 collaborators of Hans H. Lindén. A scholar is included among the top collaborators of Hans H. Lindén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans H. Lindén. Hans H. Lindén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 1
2 10
3 8
4 41
5 27
6 15
7 399
8 0
9 1

About Hans H. Lindén

Hans H. Lindén is a scholar working on Economics and Econometrics, Pharmaceutical Science and Parasitology, having authored 9 papers that have together received 502 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (5 papers), Biosimilars and Bioanalytical Methods (3 papers) and Biomedical and Engineering Education (2 papers). The work is most often cited by research in Pharmaceutical Science (266 citations), Analytical Chemistry (44 citations) and Spectroscopy (70 citations). Hans H. Lindén has collaborated with scholars based in Sweden, United Kingdom and Germany. Frequent co-authors include D. Franchi, F. Leveiller, Sven Stegemann, Hidde de Jong, Buket Aksu, Jukka Rantanen, Marcel de Matas, Thomas De Beer, João A. Lopes and Staffan Folestad. Their work appears in journals such as Nature Reviews Drug Discovery, European Journal of Pharmaceutical Sciences and Journal of Veterinary Pharmacology and Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026